November 16, 2012 at 09:03 AM EST
U.S. FTC clears Valeant deal for Medicis Pharmaceutical
Nov 16 (Reuters) - The U.S. Federal Trade Commission has cleared Valeant Pharmaceuticals International Inc's $2.6 billion deal to buy U.S. dermatology rival Medicis Pharmaceutical Corp, without conditions, Valeant said on Friday.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here